Mannatech (NASDAQ:MTEX) Stock Price Crosses Below Two Hundred Day Moving Average – Here’s Why

Mannatech, Incorporated (NASDAQ:MTEX) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.76 and traded as low as $5.65. Mannatech shares last traded at $5.64, with a volume of 6,324 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered Mannatech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday. One analyst has rated the stock with a Sell rating, According to MarketBeat, Mannatech has a consensus rating of “Sell”.

Mannatech Price Performance

The stock has a 50 day simple moving average of $5.15 and a two-hundred day simple moving average of $6.76. The company has a market cap of $10.89 million, a price-to-earnings ratio of -0.84 and a beta of 0.71. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.09 and a quick ratio of 0.59.

Mannatech (NASDAQ:MTEX) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.49 earnings per share for the quarter. The company had revenue of $24.92 million for the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 11.97%.

Insider Buying and Selling

In other Mannatech news, Director Kevin Andrew Robbins bought 7,100 shares of Mannatech stock in a transaction on Tuesday, May 19th. The shares were bought at an average price of $4.17 per share, for a total transaction of $29,607.00. Following the completion of the transaction, the director directly owned 33,333 shares of the company’s stock, valued at $138,998.61. This trade represents a 27.07% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders acquired a total of 14,903 shares of company stock valued at $62,155 in the last quarter. 41.50% of the stock is owned by insiders.

About Mannatech

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.